Choroideremia-deafness-obesity syndrome
MONDO:0010558Choroideremia-deafness-obesity syndrome is an X-linked retinal dystrophy characterized by choroideremia, causing in affected males progressive nyctalopia and eventual central blindness. Obesity, moderate intellectual disability and congenital mixed (sensorineural and conductive) deafness are also observed. Female carriers show typical retinal changes indicative of the choroideremia carrier state.
Also known as: Ayazi syndrome, Xq21 deletion syndrome, X-linked recessive, choroideremia deafness obesity, choroideremia, deafness, and intellectual disability, choroideremia, deafness, and mental retardation, choroideremia, obesity, and congenital deafness, chromosome Xq21 deletion syndrome
25 clinical trials for this condition and its sub-types, 0 tagged with Choroideremia-deafness-obesity syndrome itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
VR headsets tested as a possible treatment for blindness
Disease control Stopped earlyThis study tested whether using a virtual reality headset for one-hour sessions could help regenerate damaged optic nerves and improve vision in people with glaucoma or other retinal diseases. The idea came from promising results in rodents. However, the trial was terminated earl…
Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Scientists dig into DNA to unravel rare eye disorders
Knowledge-focused Stopped earlyThis study looked at over 100 people with inherited retinal dystrophies, a group of rare eye diseases that can cause vision loss. Researchers collected genetic and eye exam data to find links between specific gene mutations and symptoms. The goal was to better understand these di…
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC